Calcifediol
Vitamin D Deficiency
MarketedLifecycle Management
Key Facts
About Faes Farma
Faes Farma is a leading Spanish pharmaceutical group with a mission to transform health through passion, science, and innovation, achieving €627 million in revenue in 2025 with 23% year-over-year growth. Its strategy is built on a vertically integrated model, a focus on key therapeutic molecules like Bilastine and Calcifediol, and strategic acquisitions to bolster international presence and leadership in ophthalmology. The company aims to be at the forefront of excellence in health and well-being, supported by a dual business model spanning human pharmaceuticals and animal nutrition.
View full company profileOther Vitamin D Deficiency Drugs
| Drug | Company | Phase |
|---|---|---|
| Vitamin D Quantitative Test | VedaLab | Commercial |